Nimbus CEO Abbas Kazimi on Leading the Future of Precision Therapeutics
Podcasts
•
24m
Nimbus Therapeutics is transforming drug discovery with computational chemistry and AI to design small molecules that precisely target disease. CEO Abbas Kazimi, who took the helm in March, is driving a “fail fast” approach that balances discipline with innovation. He joins Inside the ICE House to share how Nimbus is scaling its pipeline and shaping the future of precision medicine.
Up Next in Podcasts
-
9-4-2025: Tariffs in Focus + Jobs Dat...
Michael Reinking, Senior Market Strategist for the NYSE, recaps a choppy week driven by tariff uncertainty, tech earnings misses, and focus on the upcoming jobs report. He notes August ended strong for small and mid-caps, but September’s seasonal weakness and rising global yields remain risks. La...
-
Eli Lilly Chief AI Officer Thomas Fuc...
AI is revolutionizing pharmaceuticals, moving from a side tool to a core driver of many aspects of the industry. Eli Lilly is leading the way, appointing Thomas Fuchs as its first Chief AI Officer to integrate AI across its pipeline. A NASA and Mount Sinai veteran, Fuchs is turning Lilly’s data i...
-
ETF Central: Parametric Managing Dire...
Alex Zweber, Portfolio Manager and Strategist at Parametric under Morgan Stanley Investment Management, joins Bilal Little, Director of Exchange Traded Products at the NYSE, to share his journey from derivatives trading to leading Parametrics' liquid alternatives team. He discusses the explosive ...